Potential of Caenorhabditis elegans as an antiaging evaluation model for dietary phytochemicals: A review
- PMID: 33337057
- DOI: 10.1111/1541-4337.12654
Potential of Caenorhabditis elegans as an antiaging evaluation model for dietary phytochemicals: A review
Abstract
Aging is an inevitable process characterized by the accumulation of degenerative damage, leading to serious diseases that affect human health. Studies on aging aim to develop pre-protection or therapies to delay aging and age-related diseases. A preventive approach is preferable to clinical treatment not only to reduce investment but also to alleviate pain in patients. Adjusting daily diet habits to improve the aging condition is a potentially attractive strategy. Fruits and vegetables containing active compounds that can effectively delay the aging process and reduce or inhibit age-related degenerative diseases have been identified. The signaling pathways related to aging in Caenorhabditis elegans are evolutionarily conserved; thus, studying antiaging components by intervening senescence process may contribute to the prevention and treatment of age-related diseases in humans. This review focuses on the effects of food-derived extracts or purified substance on antiaging in nematodes, as well as the underlying mechanisms, on the basis of several major signaling pathways and key regulatory factors in aging. The aim is to provide references for a healthy diet guidance and the development of antiaging nutritional supplements. Finally, challenges in the use of C. elegans as the antiaging evaluation model are discussed, together with the development that potentially inspire novel strategies and research tools.
Keywords: C. elegans; active compounds; antiaging; degenerative diseases; foodstuff.
© 2020 Institute of Food Technologists®.
References
REFERENCES
-
- Abbas, S., & Wink, M. (2010). Epigallocatechin gallate inhibits beta amyloid oligomerization in Caenorhabditis elegans and affects the daf-2/insulin-like signaling pathway. Phytomedicine, 17, 902-909. https://doi.org/10.1016/j.phymed.2010.03.008
-
- Alexander, A. G., Marfil, V., & Li, C. (2014). Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases. Frontiers in Genetics, 5, 279. https://doi.org/10.3389/fgene.2014.00279
-
- Altintas, O., Park, S., & Lee, S. J. (2016). The role of insulin/IGF-1 signaling in the longevity of model invertebrates, C. elegans and D. melanogaster. BMB Reports, 49, 81-92. https://doi.org/10.5483/BMBRep.2016.49.2.261
-
- Apfeld, J., O'Connor, G., McDonagh, T., DiStefano, P. S., & Curtis, R. (2004). The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Development, 18, 3004-3009. Retrieved from http://www.genesdev.org/cgi/doi/10.1101/gad.1255404
-
- Argyropoulou, A., Aligiannis, N., Trougakos, I. P., & Skaltsounis, A. L. (2013). Natural compounds with anti-ageing activity. Natural Product Reports, 30, 1412-1437. https://doi.org/10.1039/C3NP70031C
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
